We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About MycoTechnology Stock

Invest in or calculate the value of your shares in MycoTechnology or other pre-IPO companies through EquityZen's platform.

Get Started

MycoTechnology Stock (MYCT)

Fungi based food-processing platforms to transform the flavor and value of agricultural products

About MycoTechnology Stock

Founded

2013

Headquarters

Aurora, CO, US

Total Funding

82.6M

Industries

Manufacturing, Science and Engineering, Agriculture and Farming

MycoTechnology, a food technology company, utilizes fungi based food-processing platforms that aims to transform the flavor and value of agricultural products. The platform can be used to solve a variety of challenges faced by the food, beverage and flavor industries. MycoTechnology has released ClearTaste, an all natural, gmo free, organic bitter blocker that is Kosher and Halal certified. ClearTaste aims to improves the flavor of various agriculture products. MycoTechnology also engages in fermenting agricultural products with strains of gourmet fungi. The company offers myceliated chocolate as well as robusta and arabica coffee beans. It develops and licenses a technology to the industry to naturally improve the flavor of robusta and arabica coffee. The company was incorporated in 2013 and is based in Aurora, Colorado.

MycoTechnology Management

Leadership team at MycoTechnology

Founder & CSO

Brooks J. Kelly

Founder & CEO

Alan Hahn

Locked Features

Join now and verify your accreditation status to gain access to:

  • MycoTechnology current valuation
  • MycoTechnology stock price
  • Available deals in MycoTechnology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in MycoTechnology stock?

Accredited investors can buy pre-IPO stock in companies like MycoTechnology through EquityZen funds. These investments are made available by existing MycoTechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell MycoTechnology stock?

Shareholders can sell their MycoTechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."